by Ann Stewart Zachwieja | Apr 25, 2018 | Data Privacy, EU, Europe, GDPR, Int'l HR, Int'l Legal
You may have noticed that there is a big data privacy initiative coming out of the EU in the very near future – May 25, 2018, to be exact. It’s called the General Data Privacy Regulation (or GDPR) and it applies to any company that does business with or employs...
![[Podcast] Why American Companies Should Consider M&A Opportunities for Growth in Bavaria, Germany](https://globig.co/wp-content/uploads/2017/03/Germany-Skyline-956x675.png)
by Ann Stewart Zachwieja | Mar 29, 2018 | Business Expansion, Europe, Germany, Int'l HR, International Expansion, International M&A, Podcast
Globig’s partner Invest In Bavaria – US recently interviewed Melville Mummert, of Raymond James, as part of their series on North American entrepreneurs who have decided to start, settle, or build companies in Bavaria. They talked with Mr. Mummert about...
by Ann Stewart Zachwieja | Mar 27, 2018 | EU, Europe, Global HR, Int'l HR, Int'l Legal
Every year the European Union labor laws change and 2018 continues the trend. For an overview and insight into key changes that will impact companies who employ EU citizens, we spent some time with industry experts Ragu Bhargava, Co-Founder and CEO of Global...
by Ann Stewart Zachwieja | Mar 13, 2018 | EU, Europe, Global HR, Int'l HR, Int'l Legal
Every year there are changes to EU labor laws and 2018 is no exception. For an overview and insight into key changes that will impact companies who employ EU citizens, we spent some time with industry experts Ragu Bhargava, Co-Founder and CEO of Global Upside,...
![[Podcast] Why A Subsidiary In Bavaria Germany Is Ideal For This American Biotech Company](https://globig.co/wp-content/uploads/2018/10/PodcoverNewB-1080x675.jpg)
by Ann Stewart Zachwieja | Mar 7, 2018 | Business Expansion, EU, Europe, Germany, Int'l HR, Podcast
For some, relocating a biotech company to a another country may seem daunting, especially considering things such as the cost of relocation, the need and expense for high-tech and specialized testing facilities, access to good talent and scientists, and the...
